Haploinsufficient Prostate Tumor Suppression by Nkx3.1
Open Access
- 1 August 2007
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 282 (35) , 25790-25800
- https://doi.org/10.1074/jbc.m702438200
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Transcriptional signature with differential expression of BCL6 target genes accurately identifies BCL6-dependent diffuse large B cell lymphomasProceedings of the National Academy of Sciences, 2007
- Stochastic model of transcription factor-regulated gene expressionPhysical Biology, 2006
- NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN lossCancer Cell, 2006
- Effects of Histone Deacetylase Inhibitor (HDACi); Trichostatin-A (TSA) on the expression of housekeeping genesMolecular and Cellular Probes, 2006
- Mechanisms of Prostate Tumorigenesis: Roles for Transcription Factors Nkx3.1 and Egr1Annals of the New York Academy of Sciences, 2005
- Control of Stochasticity in Eukaryotic Gene ExpressionScience, 2004
- Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomasGenes & Development, 2001
- Haplo-insufficiency? Let me count the ways: Figure 1.Genes & Development, 2001
- Accommodating haploinsufficient tumour suppressor genes in Knudson's modelOncogene, 2000
- Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formationThe EMBO Journal, 1998